Found 8 results
Author Title [ Type(Desc)] Year
Filters: Author is Antin, JH  [Clear All Filters]
Journal Article
J. Tolar, Deeg, H. J., Arai, S., Horwitz, M., Antin, J. H., McCarty, J. M., Adams, R. H., Ewell, M., Leifer, E. S., Gersten, I. D., Carter, S. L., Horowitz, M. M., Nakamura, R., Pulsipher, M. A., Difronzo, N. L., Confer, D. L., Eapen, M., and Anderlini, P., Fludarabine-Based Conditioning for Marrow Transplantation From Unrelated Donors in Severe Aplastic Anemia: Early Results of a Cyclophosphamide Dose De-Escalation Study Show Life-Threatening Adverse Events at Predefined Cyclophosphamide Dose Levels, Biol Blood Marrow Transplant, vol. 18, pp. 1007-1011, 2012.
J. Bolanos-Meade, Logan, B. R., Alousi, A. M., Antin, J. H., Barowski, K., Carter, S. L., Goldstein, S. C., Hexner, E. O., Horowitz, M. M., Lee, S. J., Levine, J. E., MacMillan, M. L., Martin, P. J., Mendizabal, A. M., Nakamura, R., Pasquini, M. C., Weisdorf, D. J., Westervelt, P., and Ho, V. T., Phase 3 Clinical trial of Steroids/Mycophenolate Mofetil vs Steroids/Placebo as Therapy for Acute GVHD: BMT CTN 0802, Blood, vol. 124, pp. 3221-3227, 2014.
K. Ballen, Mendizabal, A. M., Cutler, C., Politikos, I., Jamieson, K., Shpall, E. J., Dey, B. R., Attar, E., McAfee, S., Delaney, C., McCarthy, P., Ball, E. D., Kamble, R., Avigan, D., Maziarz, R. T., Ho, V. T., Koreth, J., Alyea, E., Soiffer, R., ,, Boussiotis, V., Spitzer, T. R., and Antin, J. H., Phase II Trial of Parathyroid Hormone After Double Umbilical Cord Blood Transplantation, Biol Blood Marrow Transplant, vol. 18, no. 12, pp. 1851-1858, 2012.
A. M Zaid, Wu, J., Wu, C., Logan, B. R., Yu, J., Cutler, C., Antin, J. H., Paczesny, S., and Choi, S. W., Plasma Biomarkers of Risk for Death in a Multicenter Phase 3 trial with Uniform Transplant Characteristics Post-Allogeneic HCT, Blood, vol. 129, no. 12, pp. 162-170, 2017.
, Wilck, M. B., Dominguez, D. J., Zablowsky, E., Bajimaya, S., Gagne, L. S., Verrill, K. A., Kleinjan, J. A., Patel, A., Zhang, Y., Hill, H., Acharyya, A., Fisher, D. C., Antin, J. H., Seaman, M. S., Dolin, R., and Baden, L. R., Safety and Immunogenicity of Modified Vaccinia Ankara in Hematopoietic Stem Cell Transplant Recipients: A Randomized, Controlled Trial, J Infect Dis, vol. 207, pp. 1888-1897, 2013.
C. Cutler, Stevenson, K., Kim, H. T., Richardson, P., Ho, V. T., Linden, E., Revta, C., Ebert, R., Warren, D., Choi, S., Koreth, J., Armand, P., Alyea, E., Carter, S., Horowitz, M., Antin, J. H., and Soiffer, R., Sirolimus Is Associated With Veno-Occlusive Disease of the Liver After Myeloablative Allogeneic Stem Cell Transplantation, Blood, vol. 112, pp. 4425-4431, 2008.
C. Cutler, Logan, B., Nakamura, R., Johnston, L., Choi, S., Porter, D., Hogan, W. J., Pasquini, M., MacMillan, M. L., Hsu, J. W., Waller, E. K., Grupp, S., McCarthy, P., Wu, J., Hu, Z. H., Carter, S. L., Horowitz, M. M., and Antin, J. H., Tacrolimus/Sirolimus vs Tacrolimus/Methotrexate as GVHD Prophylaxis After Matched, Related Donor Allogeneic HCT, Blood, vol. 124, pp. 1372-1377, 2014.